185 related articles for article (PubMed ID: 32396659)
21. [Expression of fascin and CK14 in different histological types of cancer and its differential diagnostic significance].
Xue LY; Zou SM; Zheng S; Xie YQ; Wen P; Liu XY; Lin DM; Lü N
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):838-44. PubMed ID: 21223690
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours.
Provenzano E; Byrne DJ; Russell PA; Wright GM; Generali D; Fox SB
Histopathology; 2016 Feb; 68(3):367-77. PubMed ID: 26118394
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemistry as a diagnostic aid in the evaluation of ovarian tumors.
McCluggage WG; Young RH
Semin Diagn Pathol; 2005 Feb; 22(1):3-32. PubMed ID: 16512597
[TBL] [Abstract][Full Text] [Related]
24. An immunohistochemical approach to the differential diagnosis of renal tumors.
Skinnider BF; Amin MB
Semin Diagn Pathol; 2005 Feb; 22(1):51-68. PubMed ID: 16512599
[TBL] [Abstract][Full Text] [Related]
25. Eosinophilic solid and cystic renal cell carcinoma mimicking epithelioid angiomyolipoma: series of 4 primary tumors and 2 metastases.
Tretiakova MS
Hum Pathol; 2018 Oct; 80():65-75. PubMed ID: 29885406
[TBL] [Abstract][Full Text] [Related]
26. The challenge of diagnosing a malignancy metastatic to the ovary: clinicopathological characteristics vary and morphology can be different from that of the corresponding primary tumor.
Lobo J; Machado B; Vieira R; Bartosch C
Virchows Arch; 2017 Jan; 470(1):69-80. PubMed ID: 27757533
[TBL] [Abstract][Full Text] [Related]
27. The usefulness of a panel of immunostains in the diagnosis and differentiation of metastatic malignancies in pericardial effusions.
Gupta RK; Kenwright DN; Fauck R; Lallu S; Naran S
Cytopathology; 2000 Oct; 11(5):312-21. PubMed ID: 11014658
[TBL] [Abstract][Full Text] [Related]
28. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma.
Schouten LJ; Rutten J; Huveneers HA; Twijnstra A
Cancer; 2002 May; 94(10):2698-705. PubMed ID: 12173339
[TBL] [Abstract][Full Text] [Related]
29. Metastatic serous carcinoma presenting as inflammatory carcinoma over the breast-Report of two cases and literature review.
Panse G; Bossuyt V; Ko CJ
J Cutan Pathol; 2018 Mar; 45(3):234-239. PubMed ID: 29194708
[TBL] [Abstract][Full Text] [Related]
30. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
[TBL] [Abstract][Full Text] [Related]
31. Metastatic Neoplasms Involving the Stomach.
Vyas M; Hissong E; Gonzalez RS; Shia J; Jessurun J
Am J Clin Pathol; 2022 Jun; 157(6):863-873. PubMed ID: 34875001
[TBL] [Abstract][Full Text] [Related]
32. Folliculotropic Cutaneous Metastases and Lymphangitis Carcinomatosa: When Cutaneous Metastases of Breast Carcinoma Are Mistaken for Cutaneous Infections.
Paolino G; Panetta C; Didona D; Donati M; Donati P
Acta Dermatovenerol Croat; 2016 Jun; 24(2):154-7. PubMed ID: 27477179
[TBL] [Abstract][Full Text] [Related]
33. Metastatic Clear Cell Renal Carcinoma Without Evidence of a Primary Renal Tumour Mimicking Advanced Stage of Malignant Lung Tumour.
Kolečková M; Tichý T; Melichar B; Veverková L; Hes O; Kolek V; Kolář Z
Klin Onkol; 2019; 32(Supplementum1):154-156. PubMed ID: 31064187
[TBL] [Abstract][Full Text] [Related]
34. Pathologic differential diagnosis of metastatic carcinoma in the liver.
Park JH; Kim JH
Clin Mol Hepatol; 2019 Mar; 25(1):12-20. PubMed ID: 30300991
[TBL] [Abstract][Full Text] [Related]
35. Unusual primary tumors presenting as papillary carcinomas metastatic to the neck.
Dupret-Bories A; Wilt M; Kennel P; Charpiot A; Rodier JF
Ear Nose Throat J; 2015; 94(10-11):453-5. PubMed ID: 26535822
[TBL] [Abstract][Full Text] [Related]
36. Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.
Williamson SR; Gupta NS; Eble JN; Rogers CG; Michalowski S; Zhang S; Wang M; Grignon DJ; Cheng L
Am J Surg Pathol; 2015 Nov; 39(11):1502-10. PubMed ID: 26457355
[TBL] [Abstract][Full Text] [Related]
37. Cytomorphologic analysis of clear cell papillary renal cell carcinoma: Distinguishing diagnostic features.
Griffin BB; Lin X
Cancer Cytopathol; 2021 Mar; 129(3):192-203. PubMed ID: 33036062
[TBL] [Abstract][Full Text] [Related]
38. The role of cytokeratins 20 and 7 and estrogen receptor analysis in separation of metastatic lobular carcinoma of the breast and metastatic signet ring cell carcinoma of the gastrointestinal tract.
Tot T
APMIS; 2000 Jun; 108(6):467-72. PubMed ID: 11028811
[TBL] [Abstract][Full Text] [Related]
39. Utility of immunohistochemistry in distinguishing primary adenocarcinomas from metastatic breast carcinomas in the gastrointestinal tract.
O'Connell FP; Wang HH; Odze RD
Arch Pathol Lab Med; 2005 Mar; 129(3):338-47. PubMed ID: 15737028
[TBL] [Abstract][Full Text] [Related]
40. GATA3: a promising marker for metastatic breast carcinoma in serous effusion specimens.
Shield PW; Papadimos DJ; Walsh MD
Cancer Cytopathol; 2014 Apr; 122(4):307-12. PubMed ID: 24421220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
